Applied BioCode (6598.TW) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Taiwan · ISIN KYG0488D1051

Price
28.50 TWD
Market cap
2.93 bn TWD
P/E (2025)
–
P/S (2025)
6.16
Dividend yield
0.00 %
Net margin
-42.34 %
Return on equity (ROE)
-31.28 %
Return on assets (ROA)
-19.87 %

Applied BioCode financials

Fiscal year20242025
Revenue343.07 m TWD475.20 m TWD
Gross profit204.00 m TWD260.89 m TWD
Operating income-277.67 m TWD-223.33 m TWD
EBIT-259.35 m TWD-223.33 m TWD
Net income-260.81 m TWD-201.20 m TWD
Diluted EPS – continuing operations-2.88 TWD-1.96 TWD

Full history since 2012, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Applied BioCode

Applied BioCode Corporation designs, develops, and commercializes multiplex diagnostic testing products in California. Its products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the detection steps, PCR amplification, and hybridization and target capture; and the BioCode 2500 analyzer, a system that reads each barcode and quantifies the BMB target using the fluorescence signal intensity. The company develops assays, such as BioCode SARS-CoV-2 Assay, an assay for the detection of SARS-CoV-2 nucleic acid in nasopharyngeal swabs; and CoV-2 Flu Assay for detection of RNA and various Influenza, as well as offers gastrointestinal and respiratory pathogen panel related products. In addition, it provides BioCode Fungal Panel, a multiplexed deoxyribonucleic acid (DNA) amplification test; and BioCode STI + Resistance Panel (RUO), a multiplex nucleic acid amplification test. Further, the company offers barcoded magnetic bead accessories. Applied BioCode Corporation was founded in 2016 and is based in Grand Cayman, the Cayman Islands.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.